Skip to content

Popularization and application of Three-steps Tuina Therapy for treating Cervical spondylosis in clinical

Popularization and application of Three-steps Tuina Therapy for treating Cervical spondylosis in clinical

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-16008967
Enrollment
Unknown
Registered
2016-08-04
Start date
2015-06-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical spondylosis

Interventions

B:Traction
C:Traditional Tuina
A:Three-steps Tuina Therapy

Sponsors

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. To meet the diagnostic criteria of cervical spondylosis patients; 2. Without any treatment or after treatment but have a week washout period; 3. Aged 18-40 years old; 4. Agree and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Does not conform to the cervical vertebra disease diagnostic criteria and inclusion criteria; 2. Have cervical or marrow tumor, tuberculosis, or joint damage, etc.; 3. Combined cardiovascular disease or severe disease of hematopoietic system; 4. Take other drugs or treatment, the effect on the treatment of the affected persons; 5. Manual parts have serious skin damage or skin disease.

Design outcomes

Primary

MeasureTime frame
Soft tissue tension;

Secondary

MeasureTime frame
Neck Disability Index;visual analogus scale;Cervical curvature;

Countries

China

Contacts

Public ContactGu Fei

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine

gufeiking@163.com+86 18930568537

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026